SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Zangerle John Adam

(Last)

(First)

(Middle)

C/O CHANCERY HOUSE, 190 WATERSIDE ROAD

HAMILTON INDUSTRIAL PARK

(Street)

LEICESTER

LE5 1QZ

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Steris plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Gen Counsel, and Sec.

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares, 10 pence par value	11/14/2017		M		1,750⁽¹⁾	A	$36.09	29,596	D
Ordinary Shares, 10 pence par value	11/14/2017		S		1,750	D	$88	27,846	D
Ordinary Shares, 10 pence par value	11/14/2017		M		1,900⁽²⁾	A	$29.94	29,746	D
Ordinary Shares, 10 pence par value	11/14/2017		S		1,900	D	$88	27,846⁽³⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$36.09	11/14/2017		M			1,750	⁽⁴⁾	05/31/2021	Ordinary Shares	3,500	$0.00	1,750	D
Employee Stock Option (right to buy)	$29.94	11/14/2017		M			1,900	⁽⁵⁾	05/30/2022	Ordinary Shares	1,900	$0.00	0	D

Explanation of Responses:

1. This exercise and sale of a total of 1,750 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 15, 2017.

2. This exercise and sale of a total of 1,900 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on August 15, 2017.

3. 17,752 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,252 on May 30, 2018; 3,000 on May 28, 2019; 4,000 on October 1, 2019; 2,500 on June 1, 2020 and 6,000 on June 1, 2021.

4. This option to purchase 3,500 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,500 STERIS common shares for $36.09 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.

5. This option to purchase 3,800 STERIS plc ordinary shares, which is fully vested, was received in the Merger in exchange for an option to purchase 3,800 STERIS common shares for $29.94 per share, subject to the same terms and conditions as the original STERIS Corporation stock option.

Remarks:

	/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney	11/15/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.